Loading…

Differential expression of genes regulated by the glucocorticoid receptor pathway in patients with pulmonary tuberculosis

Previous studies in TB patients showed an immuno-endocrine imbalance characterized by a disease-severity associated increase in plasma levels of proinflammatory cytokines and glucocorticoids (GCs). To analyze the potential immunomodulatory effect of circulating GCs over peripheral blood mononuclear...

Full description

Saved in:
Bibliographic Details
Published in:Life sciences (1973) 2022-07, Vol.301, p.120614-120614, Article 120614
Main Authors: Gallucci, Georgina, Díaz, Ariana, Fernandez, Rocío Del Valle, Bongiovanni, Bettina, Imhoff, Matilde, Massa, Estefanía, Santucci, Natalia, Bértola, Diego, Lioi, Susana, Bay, María Luisa, Bottasso, Oscar, D'Attilio, Luciano
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c381t-e06a04e376b02e375103232a9132fd1a2883501bd376dd9a5fd357089f2bb0443
cites cdi_FETCH-LOGICAL-c381t-e06a04e376b02e375103232a9132fd1a2883501bd376dd9a5fd357089f2bb0443
container_end_page 120614
container_issue
container_start_page 120614
container_title Life sciences (1973)
container_volume 301
creator Gallucci, Georgina
Díaz, Ariana
Fernandez, Rocío Del Valle
Bongiovanni, Bettina
Imhoff, Matilde
Massa, Estefanía
Santucci, Natalia
Bértola, Diego
Lioi, Susana
Bay, María Luisa
Bottasso, Oscar
D'Attilio, Luciano
description Previous studies in TB patients showed an immuno-endocrine imbalance characterized by a disease-severity associated increase in plasma levels of proinflammatory cytokines and glucocorticoids (GCs). To analyze the potential immunomodulatory effect of circulating GCs over peripheral blood mononuclear cells (PBMC) from TB patients, we investigated the expression of positively (anti-inflammatory-related genes ANXA1; FKBP51; GILZ, NFKBIA, and NFKBIB) and negatively (inflammatory genes: IL-6, IL-1β, and IFN-γ) Glucocorticoids Receptors (GR)-regulated genes. Plasma concentrations of cytokines and hormones, together with specific lymphoproliferation were also assessed. Gene expression was quantified by RT-qPCR, specific lymphoproliferation by 3H-thymidine incorporation, whereas plasma cytokines and hormones levels by ELISA. Transcripts of ANXA1, GILZ, NFKBIB, and NFKBIA appeared significantly increased in patients, whereas FKBP51, IL-6, IL-1β, and NF-κB remained unchanged. Upon analyzing according to disease severity, mRNA levels for ANXA1 and NFKBIB were even higher in moderate and severe patients. GILZ was increased in moderate cases, with NFKBIA and IL-1 β being higher in severe ones, who also displayed increased GRβ transcripts. TB patients had reduced plasma DHEA concentrations together with increased pro and anti-inflammatory cytokines (IFN-γ, IL-6, and IL-10) cortisol and cortisol/DHEA ratio, more evident in progressive cases, in whom their PBMC also showed a decreased mycobacterial-driven proliferation. The cortisol/DHEA ratio and GRα expression were positively correlated with GR-regulated genes mainly in moderate patients. The increased expression of cortisol-regulated anti-inflammatory genes in TB patients-PBMC, predominantly in progressive disease, seems compatible with a relatively insufficient attempt to downregulate the accompanying inflammation. [Display omitted] •PBMC from TB patients have an increased expression of cortisol-regulated anti-inflammatory genes.•This may represent an attempt to reduce the chronic inflammation seen during the disease.•Severe patients have elevated mRNA levels for GRβ and IL-1β.•In part compatible with a state of resistance to GCs in these patients.
doi_str_mv 10.1016/j.lfs.2022.120614
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2661481959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320522003149</els_id><sourcerecordid>2678513155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-e06a04e376b02e375103232a9132fd1a2883501bd376dd9a5fd357089f2bb0443</originalsourceid><addsrcrecordid>eNp9kUuPFCEUhYnROO3oD3BjSNy4qfYCRT3iyozPZBI3uiYUXLrp0EUJ1Iz976XTowsXri7J_c7J5RxCXjLYMmDd28M2uLzlwPmWcehY-4hs2NCPDXSCPSYbAN42goO8Is9yPgCAlL14Sq6ElLyTI9uQ0wfvHCaci9eB4q8lYc4-zjQ6usMZM024W4MuaOl0omWPdBdWE01MxZvobd0bXEpMdNFlf69P1M_np6-Wmd77sqfLGo5x1qnK1wmTWUPMPj8nT5wOGV88zGvy49PH7zdfmttvn7_evL9tjBhYaRA6DS2KvpuA1yEZCC64HpngzjLNh0FIYJOthLWjls4K2cMwOj5N0Lbimry5-C4p_lwxF3X02WAIesa4ZsW7GtzARjlW9PU_6CGuaa7XVaofJBNMykqxC2VSzDmhU0vyx_o9xUCde1EHVXtR517UpZeqefXgvE5HtH8Vf4qowLsLgDWKO49JZVMjNGh9DbgoG_1_7H8Ds3ye2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678513155</pqid></control><display><type>article</type><title>Differential expression of genes regulated by the glucocorticoid receptor pathway in patients with pulmonary tuberculosis</title><source>ScienceDirect Freedom Collection</source><creator>Gallucci, Georgina ; Díaz, Ariana ; Fernandez, Rocío Del Valle ; Bongiovanni, Bettina ; Imhoff, Matilde ; Massa, Estefanía ; Santucci, Natalia ; Bértola, Diego ; Lioi, Susana ; Bay, María Luisa ; Bottasso, Oscar ; D'Attilio, Luciano</creator><creatorcontrib>Gallucci, Georgina ; Díaz, Ariana ; Fernandez, Rocío Del Valle ; Bongiovanni, Bettina ; Imhoff, Matilde ; Massa, Estefanía ; Santucci, Natalia ; Bértola, Diego ; Lioi, Susana ; Bay, María Luisa ; Bottasso, Oscar ; D'Attilio, Luciano</creatorcontrib><description>Previous studies in TB patients showed an immuno-endocrine imbalance characterized by a disease-severity associated increase in plasma levels of proinflammatory cytokines and glucocorticoids (GCs). To analyze the potential immunomodulatory effect of circulating GCs over peripheral blood mononuclear cells (PBMC) from TB patients, we investigated the expression of positively (anti-inflammatory-related genes ANXA1; FKBP51; GILZ, NFKBIA, and NFKBIB) and negatively (inflammatory genes: IL-6, IL-1β, and IFN-γ) Glucocorticoids Receptors (GR)-regulated genes. Plasma concentrations of cytokines and hormones, together with specific lymphoproliferation were also assessed. Gene expression was quantified by RT-qPCR, specific lymphoproliferation by 3H-thymidine incorporation, whereas plasma cytokines and hormones levels by ELISA. Transcripts of ANXA1, GILZ, NFKBIB, and NFKBIA appeared significantly increased in patients, whereas FKBP51, IL-6, IL-1β, and NF-κB remained unchanged. Upon analyzing according to disease severity, mRNA levels for ANXA1 and NFKBIB were even higher in moderate and severe patients. GILZ was increased in moderate cases, with NFKBIA and IL-1 β being higher in severe ones, who also displayed increased GRβ transcripts. TB patients had reduced plasma DHEA concentrations together with increased pro and anti-inflammatory cytokines (IFN-γ, IL-6, and IL-10) cortisol and cortisol/DHEA ratio, more evident in progressive cases, in whom their PBMC also showed a decreased mycobacterial-driven proliferation. The cortisol/DHEA ratio and GRα expression were positively correlated with GR-regulated genes mainly in moderate patients. The increased expression of cortisol-regulated anti-inflammatory genes in TB patients-PBMC, predominantly in progressive disease, seems compatible with a relatively insufficient attempt to downregulate the accompanying inflammation. [Display omitted] •PBMC from TB patients have an increased expression of cortisol-regulated anti-inflammatory genes.•This may represent an attempt to reduce the chronic inflammation seen during the disease.•Severe patients have elevated mRNA levels for GRβ and IL-1β.•In part compatible with a state of resistance to GCs in these patients.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2022.120614</identifier><identifier>PMID: 35526591</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Annexin A1 ; Blood circulation ; Cortisol ; Cytokines ; Dehydroepiandrosterone ; Enzyme-linked immunosorbent assay ; Gene expression ; Genes ; GILZ ; Glucocorticoid receptor ; Glucocorticoids ; Hormones ; IL-1β ; Immunomodulation ; Inflammation ; Interleukin 1 ; Interleukin 10 ; Interleukin 6 ; Leukocytes (mononuclear) ; NF-κB inhibitors ; NF-κB protein ; Peripheral blood mononuclear cells ; Plasma ; Plasma levels ; Receptors ; Thymidine ; Tuberculosis ; γ-Interferon</subject><ispartof>Life sciences (1973), 2022-07, Vol.301, p.120614-120614, Article 120614</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier BV Jul 15, 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-e06a04e376b02e375103232a9132fd1a2883501bd376dd9a5fd357089f2bb0443</citedby><cites>FETCH-LOGICAL-c381t-e06a04e376b02e375103232a9132fd1a2883501bd376dd9a5fd357089f2bb0443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35526591$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gallucci, Georgina</creatorcontrib><creatorcontrib>Díaz, Ariana</creatorcontrib><creatorcontrib>Fernandez, Rocío Del Valle</creatorcontrib><creatorcontrib>Bongiovanni, Bettina</creatorcontrib><creatorcontrib>Imhoff, Matilde</creatorcontrib><creatorcontrib>Massa, Estefanía</creatorcontrib><creatorcontrib>Santucci, Natalia</creatorcontrib><creatorcontrib>Bértola, Diego</creatorcontrib><creatorcontrib>Lioi, Susana</creatorcontrib><creatorcontrib>Bay, María Luisa</creatorcontrib><creatorcontrib>Bottasso, Oscar</creatorcontrib><creatorcontrib>D'Attilio, Luciano</creatorcontrib><title>Differential expression of genes regulated by the glucocorticoid receptor pathway in patients with pulmonary tuberculosis</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Previous studies in TB patients showed an immuno-endocrine imbalance characterized by a disease-severity associated increase in plasma levels of proinflammatory cytokines and glucocorticoids (GCs). To analyze the potential immunomodulatory effect of circulating GCs over peripheral blood mononuclear cells (PBMC) from TB patients, we investigated the expression of positively (anti-inflammatory-related genes ANXA1; FKBP51; GILZ, NFKBIA, and NFKBIB) and negatively (inflammatory genes: IL-6, IL-1β, and IFN-γ) Glucocorticoids Receptors (GR)-regulated genes. Plasma concentrations of cytokines and hormones, together with specific lymphoproliferation were also assessed. Gene expression was quantified by RT-qPCR, specific lymphoproliferation by 3H-thymidine incorporation, whereas plasma cytokines and hormones levels by ELISA. Transcripts of ANXA1, GILZ, NFKBIB, and NFKBIA appeared significantly increased in patients, whereas FKBP51, IL-6, IL-1β, and NF-κB remained unchanged. Upon analyzing according to disease severity, mRNA levels for ANXA1 and NFKBIB were even higher in moderate and severe patients. GILZ was increased in moderate cases, with NFKBIA and IL-1 β being higher in severe ones, who also displayed increased GRβ transcripts. TB patients had reduced plasma DHEA concentrations together with increased pro and anti-inflammatory cytokines (IFN-γ, IL-6, and IL-10) cortisol and cortisol/DHEA ratio, more evident in progressive cases, in whom their PBMC also showed a decreased mycobacterial-driven proliferation. The cortisol/DHEA ratio and GRα expression were positively correlated with GR-regulated genes mainly in moderate patients. The increased expression of cortisol-regulated anti-inflammatory genes in TB patients-PBMC, predominantly in progressive disease, seems compatible with a relatively insufficient attempt to downregulate the accompanying inflammation. [Display omitted] •PBMC from TB patients have an increased expression of cortisol-regulated anti-inflammatory genes.•This may represent an attempt to reduce the chronic inflammation seen during the disease.•Severe patients have elevated mRNA levels for GRβ and IL-1β.•In part compatible with a state of resistance to GCs in these patients.</description><subject>Annexin A1</subject><subject>Blood circulation</subject><subject>Cortisol</subject><subject>Cytokines</subject><subject>Dehydroepiandrosterone</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Gene expression</subject><subject>Genes</subject><subject>GILZ</subject><subject>Glucocorticoid receptor</subject><subject>Glucocorticoids</subject><subject>Hormones</subject><subject>IL-1β</subject><subject>Immunomodulation</subject><subject>Inflammation</subject><subject>Interleukin 1</subject><subject>Interleukin 10</subject><subject>Interleukin 6</subject><subject>Leukocytes (mononuclear)</subject><subject>NF-κB inhibitors</subject><subject>NF-κB protein</subject><subject>Peripheral blood mononuclear cells</subject><subject>Plasma</subject><subject>Plasma levels</subject><subject>Receptors</subject><subject>Thymidine</subject><subject>Tuberculosis</subject><subject>γ-Interferon</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUuPFCEUhYnROO3oD3BjSNy4qfYCRT3iyozPZBI3uiYUXLrp0EUJ1Iz976XTowsXri7J_c7J5RxCXjLYMmDd28M2uLzlwPmWcehY-4hs2NCPDXSCPSYbAN42goO8Is9yPgCAlL14Sq6ElLyTI9uQ0wfvHCaci9eB4q8lYc4-zjQ6usMZM024W4MuaOl0omWPdBdWE01MxZvobd0bXEpMdNFlf69P1M_np6-Wmd77sqfLGo5x1qnK1wmTWUPMPj8nT5wOGV88zGvy49PH7zdfmttvn7_evL9tjBhYaRA6DS2KvpuA1yEZCC64HpngzjLNh0FIYJOthLWjls4K2cMwOj5N0Lbimry5-C4p_lwxF3X02WAIesa4ZsW7GtzARjlW9PU_6CGuaa7XVaofJBNMykqxC2VSzDmhU0vyx_o9xUCde1EHVXtR517UpZeqefXgvE5HtH8Vf4qowLsLgDWKO49JZVMjNGh9DbgoG_1_7H8Ds3ye2A</recordid><startdate>20220715</startdate><enddate>20220715</enddate><creator>Gallucci, Georgina</creator><creator>Díaz, Ariana</creator><creator>Fernandez, Rocío Del Valle</creator><creator>Bongiovanni, Bettina</creator><creator>Imhoff, Matilde</creator><creator>Massa, Estefanía</creator><creator>Santucci, Natalia</creator><creator>Bértola, Diego</creator><creator>Lioi, Susana</creator><creator>Bay, María Luisa</creator><creator>Bottasso, Oscar</creator><creator>D'Attilio, Luciano</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20220715</creationdate><title>Differential expression of genes regulated by the glucocorticoid receptor pathway in patients with pulmonary tuberculosis</title><author>Gallucci, Georgina ; Díaz, Ariana ; Fernandez, Rocío Del Valle ; Bongiovanni, Bettina ; Imhoff, Matilde ; Massa, Estefanía ; Santucci, Natalia ; Bértola, Diego ; Lioi, Susana ; Bay, María Luisa ; Bottasso, Oscar ; D'Attilio, Luciano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-e06a04e376b02e375103232a9132fd1a2883501bd376dd9a5fd357089f2bb0443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Annexin A1</topic><topic>Blood circulation</topic><topic>Cortisol</topic><topic>Cytokines</topic><topic>Dehydroepiandrosterone</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Gene expression</topic><topic>Genes</topic><topic>GILZ</topic><topic>Glucocorticoid receptor</topic><topic>Glucocorticoids</topic><topic>Hormones</topic><topic>IL-1β</topic><topic>Immunomodulation</topic><topic>Inflammation</topic><topic>Interleukin 1</topic><topic>Interleukin 10</topic><topic>Interleukin 6</topic><topic>Leukocytes (mononuclear)</topic><topic>NF-κB inhibitors</topic><topic>NF-κB protein</topic><topic>Peripheral blood mononuclear cells</topic><topic>Plasma</topic><topic>Plasma levels</topic><topic>Receptors</topic><topic>Thymidine</topic><topic>Tuberculosis</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gallucci, Georgina</creatorcontrib><creatorcontrib>Díaz, Ariana</creatorcontrib><creatorcontrib>Fernandez, Rocío Del Valle</creatorcontrib><creatorcontrib>Bongiovanni, Bettina</creatorcontrib><creatorcontrib>Imhoff, Matilde</creatorcontrib><creatorcontrib>Massa, Estefanía</creatorcontrib><creatorcontrib>Santucci, Natalia</creatorcontrib><creatorcontrib>Bértola, Diego</creatorcontrib><creatorcontrib>Lioi, Susana</creatorcontrib><creatorcontrib>Bay, María Luisa</creatorcontrib><creatorcontrib>Bottasso, Oscar</creatorcontrib><creatorcontrib>D'Attilio, Luciano</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gallucci, Georgina</au><au>Díaz, Ariana</au><au>Fernandez, Rocío Del Valle</au><au>Bongiovanni, Bettina</au><au>Imhoff, Matilde</au><au>Massa, Estefanía</au><au>Santucci, Natalia</au><au>Bértola, Diego</au><au>Lioi, Susana</au><au>Bay, María Luisa</au><au>Bottasso, Oscar</au><au>D'Attilio, Luciano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential expression of genes regulated by the glucocorticoid receptor pathway in patients with pulmonary tuberculosis</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2022-07-15</date><risdate>2022</risdate><volume>301</volume><spage>120614</spage><epage>120614</epage><pages>120614-120614</pages><artnum>120614</artnum><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Previous studies in TB patients showed an immuno-endocrine imbalance characterized by a disease-severity associated increase in plasma levels of proinflammatory cytokines and glucocorticoids (GCs). To analyze the potential immunomodulatory effect of circulating GCs over peripheral blood mononuclear cells (PBMC) from TB patients, we investigated the expression of positively (anti-inflammatory-related genes ANXA1; FKBP51; GILZ, NFKBIA, and NFKBIB) and negatively (inflammatory genes: IL-6, IL-1β, and IFN-γ) Glucocorticoids Receptors (GR)-regulated genes. Plasma concentrations of cytokines and hormones, together with specific lymphoproliferation were also assessed. Gene expression was quantified by RT-qPCR, specific lymphoproliferation by 3H-thymidine incorporation, whereas plasma cytokines and hormones levels by ELISA. Transcripts of ANXA1, GILZ, NFKBIB, and NFKBIA appeared significantly increased in patients, whereas FKBP51, IL-6, IL-1β, and NF-κB remained unchanged. Upon analyzing according to disease severity, mRNA levels for ANXA1 and NFKBIB were even higher in moderate and severe patients. GILZ was increased in moderate cases, with NFKBIA and IL-1 β being higher in severe ones, who also displayed increased GRβ transcripts. TB patients had reduced plasma DHEA concentrations together with increased pro and anti-inflammatory cytokines (IFN-γ, IL-6, and IL-10) cortisol and cortisol/DHEA ratio, more evident in progressive cases, in whom their PBMC also showed a decreased mycobacterial-driven proliferation. The cortisol/DHEA ratio and GRα expression were positively correlated with GR-regulated genes mainly in moderate patients. The increased expression of cortisol-regulated anti-inflammatory genes in TB patients-PBMC, predominantly in progressive disease, seems compatible with a relatively insufficient attempt to downregulate the accompanying inflammation. [Display omitted] •PBMC from TB patients have an increased expression of cortisol-regulated anti-inflammatory genes.•This may represent an attempt to reduce the chronic inflammation seen during the disease.•Severe patients have elevated mRNA levels for GRβ and IL-1β.•In part compatible with a state of resistance to GCs in these patients.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>35526591</pmid><doi>10.1016/j.lfs.2022.120614</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2022-07, Vol.301, p.120614-120614, Article 120614
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_2661481959
source ScienceDirect Freedom Collection
subjects Annexin A1
Blood circulation
Cortisol
Cytokines
Dehydroepiandrosterone
Enzyme-linked immunosorbent assay
Gene expression
Genes
GILZ
Glucocorticoid receptor
Glucocorticoids
Hormones
IL-1β
Immunomodulation
Inflammation
Interleukin 1
Interleukin 10
Interleukin 6
Leukocytes (mononuclear)
NF-κB inhibitors
NF-κB protein
Peripheral blood mononuclear cells
Plasma
Plasma levels
Receptors
Thymidine
Tuberculosis
γ-Interferon
title Differential expression of genes regulated by the glucocorticoid receptor pathway in patients with pulmonary tuberculosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-03T18%3A26%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20expression%20of%20genes%20regulated%20by%20the%20glucocorticoid%20receptor%20pathway%20in%20patients%20with%20pulmonary%20tuberculosis&rft.jtitle=Life%20sciences%20(1973)&rft.au=Gallucci,%20Georgina&rft.date=2022-07-15&rft.volume=301&rft.spage=120614&rft.epage=120614&rft.pages=120614-120614&rft.artnum=120614&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2022.120614&rft_dat=%3Cproquest_cross%3E2678513155%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c381t-e06a04e376b02e375103232a9132fd1a2883501bd376dd9a5fd357089f2bb0443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2678513155&rft_id=info:pmid/35526591&rfr_iscdi=true